Sterol absorption inhibitor compounds
    1.
    发明申请
    Sterol absorption inhibitor compounds 审中-公开
    甾醇吸收抑制剂化合物

    公开(公告)号:US20060199793A1

    公开(公告)日:2006-09-07

    申请号:US11158429

    申请日:2005-06-22

    IPC分类号: A61K31/397 A61K31/192

    摘要: The present invention provides compositions, therapeutic combinations and methods including: (a) at least one peroxisome proliferator-activated receptor activator; and (b) at least one substituted azetidinone or substituted β-lactam sterol absorption inhibitor which can be useful for treating vascular conditions, diabetes, obesity and lowering plasma levels of sterols.

    摘要翻译: 本发明提供组合物,治疗组合和方法,包括:(a)至少一种过氧化物酶体增殖物激活受体激活剂; 和(b)至少一种取代的氮杂环丁酮或取代的β-内酰胺甾醇吸收抑制剂,其可用于治疗血管疾病,糖尿病,肥胖症和降低甾醇的血浆水平。

    DUPLEXER WITH SIGNAL CANCELLATION
    3.
    发明申请

    公开(公告)号:US20180175902A1

    公开(公告)日:2018-06-21

    申请号:US15739055

    申请日:2016-06-27

    摘要: A wireless communication system has a base station operative to communicate wirelessly with a plurality of customer devices. The base station has a circulator with a first port connected to one or more signal transmission devices, a second port that is connected to one or more antennas, and a third port that is connected to one or more signal reception devices. The circulator communicates transmission signals from the one or more signal transmission devices to the one or more antennas, and communicates received signals from the one or more antennas to the one or more signal reception devices. The plurality of customers devices have cancellation/separation duplexers or circulators.

    Use of substituted azetidinone compounds for the treatment of sitosterolemia
    6.
    发明申请
    Use of substituted azetidinone compounds for the treatment of sitosterolemia 审中-公开
    使用取代的氮杂环丁酮化合物治疗静脉麻醉

    公开(公告)号:US20060287254A1

    公开(公告)日:2006-12-21

    申请号:US11437454

    申请日:2006-05-19

    申请人: Harry Davis

    发明人: Harry Davis

    摘要: The present invention is directed to pharmaceutical compositions comprising a sterol absorption inhibitor, a CEPT inhibitor and/or an HMG-CoA reductase inhibitor as well as methods for treating sitosterolemia, hypercholesterolemia, hyperlipidemia, atherosclerosis, mixed dyslopidemia, vascular events prevention and related disorders in a mammal in need thereof by administering said pharmaceutical compositions to the mammal.

    摘要翻译: 本发明涉及包含甾醇吸收抑制剂,CEPT抑制剂和/或HMG-CoA还原酶抑制剂的药物组合物,以及用于治疗静脉硬化,高胆固醇血症,高脂血症,动脉粥样硬化,混合性异常血症,血管事件预防和相关疾病的方法 通过向哺乳动物施用所述药物组合物来治疗需要的哺乳动物。

    Duplexer with signal cancellation

    公开(公告)号:US10454662B2

    公开(公告)日:2019-10-22

    申请号:US15039640

    申请日:2014-11-21

    IPC分类号: H04L5/14 H04B1/525 H04B7/26

    摘要: There is provided a duplexer having first, second and third ports and adapted for connection between an antenna and uplink and downlink, respectively, in a full duplex communication system. The duplexer has first and second quarter wave transformers connected between the first and third and between the first and second ports, respectively. The duplexer has a balancing resistor connected between the third port and the output of the second transformer. The duplexer has a filter circuit connected between the output of the second transformer and the second port.